Comment period closed: July 30, 2013
Background:
Dow AgroSciences Canada Inc. (DAS) has submitted to the Plant Biosafety Office and Animal Feed Division of the Canadian Food Inspection Agency and Health Canada a submission to approve DAS-81419-2 (genetically modified to be insect-resistant) for environmental release, livestock feed and food use and make a determination that this modified plant is safe. This submission is in accordance with Directive 94-08 (Dir94-08),“Assessment Criteria for Determining Environmental Safety of Plants with Novel Traits”; Section 2.6 of Regulatory Guidance: Feed Registration Procedures and Labeling Standards; and Guidelines for the Safety Assessment of Novel Foods.
Summary of the Submission
Updated scientific information may be added to this submission by the developer at a later date, or CFIA and/or Health Canada may request further information from the developer.
| Description of the host plant |
Please refer to Biology Document BIO1996-10: The Biology of Glycine max (L.) Merr. (Soybean)
|
|---|---|
| Description of the Modification and Inheritance and Stability of the Introduced Trait |
DAS-81419-2 was developed through recombinant DNA technology. In order to assess the modification process the following has been submitted:
|
| Description of the Novel Traits |
In order to characterize the DNA inserted in 81419-2, the following has been submitted:
|
| Toxicity and Allergenicity of the Novel Gene Products |
In order to assess toxicity and allergenicity of the novel genes on non-target species, humans and animals the following has been submitted:
|
| Nutritional Evaluation of DAS-81419-2 |
In order to assess nutritional aspects of DAS-81419-2 the following has been submitted:
|
| Evaluation of the Environmental Impact of DAS-81419-2 |
In order to assess environmental impact of DAS-81419-2 the following has been submitted:
|
| Stewardship of DAS-81419-2 |
To assess stewardship of DAS-81419-2 the following has been submitted:
|
Comments will be received only via the Internet or postal mail to CFIA or Health Canada.
For more information on this product, please contact:
Dow AgroSciences Canada Inc.
Suite 2100, 450-1st Street SW
Calgary, AB
T2P 5H1
The CFIA and Health Canada, including their employees, are not responsible for the content of this Notice of Submission as submitted by the Applicant. All Notices of Submission are the responsibility of the Applicant submitting them and the Applicant does so at their own risk. Submission of this Notice of Submission and its subsequent posting by the CFIA on its website does not in any way whatsoever constitute acceptance, approval or certification by the CFIA or Health Canada of the Plant with Novel Trait(s) subject of the Notice of Submission and the CFIA and Health Canada reserve all their rights under all the pertinent legislation that may be applicable. The CFIA and Health Canada in no way whatsoever waives any of their rights under any of the legislation they enforce or administer by way of the CFIA posting this Notice of Submission.
The Applicant is not required to provide a Notice of Submission. The information that the Applicant voluntarily provides on this Notice of Submission is collected by the CFIA and Health Canada for the purpose of sharing information with the public. Personal Information will be protected under the provisions of the Privacy Act, and will be stored in Personal Information Bank CFIA PPU 125. Information, including personal information, may be accessible or protected as required under the provisions of the Access to Information Act.